In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
UCB's pioneering, scientific presence at the 2016 ACR/ARHP Annual Meeting include data on CIMZIA® (certolizumab pegol) across five immunologic disease states and on romosozumab in osteoporosis from multiple Phase 3 studies. Key oral presentations include: